Drug interactions
Idecabtagene vicleucel + Interferon beta 1a
Severity: Major
Idecabtagene vicleucel and Interferon beta 1a: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Idecabtagene vicleucel is a CAR-T cell therapy that causes prolonged cytopenias and immune compromise. Interferon beta may add to immune and marrow effects and could influence CAR-T cell activity or expansion. The combined effect on infection risk and on CAR-T efficacy is not well characterized.
What this interaction means in plain words
Idecabtagene vicleucel and Interferon beta 1a can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Idecabtagene vicleucel belongs to Oncology; Interferon beta 1a belongs to Central Nervous System.
Why it happens
Additive immunosuppressive and myelosuppressive effects; the effect of interferon on CAR-T cell expansion and function is not established.
What to do
Avoid interferon beta around CAR-T infusion and consider alternative multiple sclerosis therapy. If it cannot be avoided, monitor blood counts and infection signs closely.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Idecabtagene vicleucel and Interferon beta 1a, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Interferon beta 1a
Other interactions of Idecabtagene vicleucel
Frequently asked questions
Can I take Idecabtagene vicleucel with Interferon beta 1a?
MediHelp rates the interaction as major. Idecabtagene vicleucel and Interferon beta 1a can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Idecabtagene vicleucel is a CAR-T cell therapy that causes prolonged cytopenias and immune compromise. Interferon beta may add to immune and marrow effects and could influence CAR-T cell activity or expansion. The combined effect on infection risk and on CAR-T efficacy is not well characterized.
How serious is the interaction between Idecabtagene vicleucel and Interferon beta 1a?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid interferon beta around CAR-T infusion and consider alternative multiple sclerosis therapy. If it cannot be avoided, monitor blood counts and infection signs closely.
What other medicines interact with Interferon beta 1a?
MediHelp also lists interactions of Interferon beta 1a with, for example, Deferiprone, Etrasimod, Hydroxyurea. The full list is on the Interferon beta 1a page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
